Hutchison China MediTech Ltd ADR buy melinda
Start price
12.03.18
/
50%
€33.42
Target price
12.09.18
€40.59
Performance (%)
-26.30%
End price
12.09.18
€24.63
Summary
This prediction ended on 12.09.18 with a price of €24.63. The price of Hutchison China MediTech Ltd ADR has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -26.30%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Hutchison China MediTech Ltd ADR | -7.377% | -7.377% | -12.403% | -16.296% |
| iShares Core DAX® | -1,50 % | 7,70 % | 5,24 % | 46,96 % |
| iShares Nasdaq 100 | 1,38 % | 16,28 % | 36,09 % | 95,84 % |
| iShares Nikkei 225® | -1,99 % | 13,11 % | 40,18 % | 62,92 % |
| iShares S&P 500 | 0,35 % | 10,82 % | 26,47 % | 67,25 % |
Comments by melinda for this prediction
In the thread Hutchison China MediTech Ltd ADR diskutieren
Pharmazeutische SecteurProduits Agenda 12/03 | 08.00 Uhr veröffentlichte Ergebnisse
Hutchison China Meditech wendet sich an die erste Arzneimittelzulassung in diesem Jahr
(Laufzeit überschritten)